市場調査レポート

商品コード

1472342

エピネフリンの世界市場：製品タイプ別、用途別、流通チャネル別：機会分析と産業予測（2023年～2032年）

Epinephrine Market By Product Type, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2024年03月01日 | 発行: Allied Market Research

| ページ情報: 英文 266 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,168円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,730 899,094円

レポートPDFをご利用いただけるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,506,336円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.91円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のエピネフリンの市場規模は、2022年に26億米ドルと評価され、2023年～2032年のCAGRは5.6％を記録し、2032年には44億米ドルに達すると予測されています。

アドレナリンとしても知られるエピネフリンは、ストレスや危険に対する身体の反応に重要な役割を果たすホルモンおよび神経伝達物質です。腎臓の上部にある副腎で産生されます。エピネフリンは、恐怖、ストレス、興奮などのさまざまな刺激に反応して血流中に放出されます。いったん放出されると、エピネフリンは体を行動に備えることを目的とした一連の生理的反応を引き起こします。これらの反応には、心拍数の増加、血圧の上昇、酸素摂取を改善するための肺の気道拡張、筋肉への血流の方向転換などが含まれます。エピネフリンはまた、覚醒と意識を高め、課題への素早い反応を助けます。

例えば、アナフィラキシー（重篤なアレルギー反応）、心停止、気管支痙攣、その他の不整脈の際に医薬品として使用されます。患者はエピネフリンを注射や吸入、あるいは鼻腔スプレーで服用します。その結果、空気の流入やエネルギーの利用可能性などのメカニズムを通じて血液の循環速度を増加させることで、激しい肉体的労作や知覚された脅威に備えることができます。

エピネフリン市場は、アナフィラキシー、喘息、食物アレルギーなどのアレルギー症状の発生率の増加によって牽引されています。これらは、第一選択の治療としてエピネフリンの使用を必要とするような、強く致死的な反応を引き起こす可能性があります。例えば、米国アレルギー・喘息・免疫学会（ACAAI）によると、2021年現在、米国では約2,000万人が食物アレルギーを持っています。アナフィラキシーは、壊滅的な食物アレルギーを持つ人が誤って食物アレルギー源に触れた場合、呼吸困難、喉の腫れ、血圧の急激な低下などを引き起こす重篤で時に致命的なアレルギー反応です。このような場合、危険な症状に対処するためにエピネフリンの迅速な投与が不可欠であり、これがエピネフリンの需要を牽引しています。

さらに、救急医療サービス（EMS）の成長も、業界内のエピネフリン需要を促進するのに役立っています。心停止やアナフィラキシーなど、生命を脅かす様々な症例に対応する救急隊員や第一応答者は、通常この薬を投与されるため、救急医療キットの一部を形成しています。救急医療サービスの利用しやすさ、利用しやすさの向上と救急医療需要の増加が、エピネフリンの需要拡大に大きく寄与しています。

さらに、人口の高齢化もエピネフリン市場の成長に寄与する要因です。高齢になると、アレルギー反応や、喘息や慢性閉塞性肺疾患（COPD）などの慢性呼吸器疾患にかかりやすくなります。このような場合、エピネフリンは重篤な症状を管理し合併症を予防するための救命薬として処方されることがあり、これが市場の成長を支えています。

しかし、エピネフリン製品に対する規制上の課題や厳しい承認プロセスが市場の成長を制限する可能性があります。規制当局は、エピネフリン製剤の安全性と有効性を確保するために、製造、表示、流通に厳格な基準を課すことが多く、製品上市の遅延や製造業者のコスト増につながり、市場成長にマイナスの影響を与えています。これとは対照的に、より使いやすく便利なエピネフリン自動注射器の開発など、ドラッグデリバリーシステムの技術的進歩は、患者のコンプライアンスと市場浸透を高めます。製剤技術、包装設計、デバイスの使いやすさなどにおけるこのような技術革新は、予測期間中に市場成長の有利な機会を生み出すと期待されています。

エピネフリン市場は、製品タイプ、用途、流通チャネル、地域によって区分されます。製品タイプ別では、市場は自動注射器、プレフィルドシリンジ、その他に分類されます。用途別では、市場はアナフィラキシー、心停止、その他に分けられます。流通チャネル別では、院内薬局、ドラッグストア・小売薬局、オンライン薬局に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、その他アジア太平洋）、ラテンアメリカ（ブラジル、コロンビア、アルゼンチン、その他ラテンアメリカ）、中東・アフリカ（GCC諸国、南アフリカ、北アフリカ、その他中東・アフリカ）に分けて分析しています。

利害関係者にとっての主なメリット

当レポートでは、2022年～2032年のエピネフリン市場分析の市場セグメント、現在の動向、推定・動向、力学を定量的に分析し、優勢なエピネフリン市場機会を特定します。

市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。

ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。

エピネフリン市場のセグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。

各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。

市場企業のポジショニングは、ベンチマーキングを容易にし、市場企業の現在のポジションの明確な理解を提供します。

本レポートには、地域別および世界のエピネフリン市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートで可能なレポートカスタマイズ（追加費用とタイムラインに関しましては販売担当へご連絡ください）

規制ガイドライン
顧客の関心に応じた企業プロファイルの追加
国別または地域別の追加分析：市場規模と予測
企業プロファイルの拡張リスト
過去の市場データ
主要企業の詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他
ラテンアメリカ
- ブラジル
- コロンビア
- アルゼンチン
- その他
中東・アフリカ
- GCC諸国
- 南アフリカ
- 北アフリカ
- その他

第8章競争情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング（2022年）

第9章企業プロファイル

Adamis Pharmaceuticals Corporation
AdvaCare Pharma
ALK
Amneal Pharmaceuticals LLC.
Amphastar Pharmaceuticals, Inc.
Grand Pharma（China）Co., Ltd.
kaleo, Inc.
Pfizer
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

図表

LIST OF TABLES

TABLE 01. GLOBAL EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. EPINEPHRINE MARKET FOR AUTO-INJECTOR, BY REGION, 2022-2032 ($MILLION)
TABLE 03. EPINEPHRINE MARKET FOR PREFILLED SYRINGE, BY REGION, 2022-2032 ($MILLION)
TABLE 04. EPINEPHRINE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 06. EPINEPHRINE MARKET FOR ANAPHYLAXIS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. EPINEPHRINE MARKET FOR CARDIAC ARREST, BY REGION, 2022-2032 ($MILLION)
TABLE 08. EPINEPHRINE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 10. EPINEPHRINE MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 11. EPINEPHRINE MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 12. EPINEPHRINE MARKET FOR ONLINE PROVIDERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. EPINEPHRINE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA EPINEPHRINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 18. U.S. EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 19. U.S. EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 20. U.S. EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 21. CANADA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 22. CANADA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 24. MEXICO EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 25. MEXICO EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 27. EUROPE EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 28. EUROPE EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 30. EUROPE EPINEPHRINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 31. GERMANY EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 32. GERMANY EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. GERMANY EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 34. FRANCE EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 35. FRANCE EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 37. UK EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 38. UK EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. UK EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 40. ITALY EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 41. ITALY EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 43. SPAIN EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 44. SPAIN EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC EPINEPHRINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. JAPAN EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 54. JAPAN EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 55. JAPAN EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 56. CHINA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 57. CHINA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 59. INDIA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 60. INDIA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. INDIA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 71. LATIN AMERICA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 72. LATIN AMERICA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 73. LATIN AMERICA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 74. LATIN AMERICA EPINEPHRINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 75. BRAZIL EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 76. BRAZIL EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 77. BRAZIL EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 78. COLOMBIA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 79. COLOMBIA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. COLOMBIA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 81. ARGENTINA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 82. ARGENTINA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. ARGENTINA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 84. REST OF LA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 85. REST OF LA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. REST OF LA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 87. MIDDLE EAST AND AFRICA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 88. MIDDLE EAST AND AFRICA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. MIDDLE EAST AND AFRICA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 90. MIDDLE EAST AND AFRICA EPINEPHRINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 91. GCC EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 92. GCC EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 93. GCC EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 94. SOUTH AFRICA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 95. SOUTH AFRICA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 96. SOUTH AFRICA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 97. NORTH AFRICA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 98. NORTH AFRICA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 99. NORTH AFRICA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 100. REST OF MEA EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 101. REST OF MEA EPINEPHRINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 102. REST OF MEA EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 103. ADAMIS PHARMACEUTICALS CORPORATION: KEY EXECUTIVES
TABLE 104. ADAMIS PHARMACEUTICALS CORPORATION: COMPANY SNAPSHOT
TABLE 105. ADAMIS PHARMACEUTICALS CORPORATION: PRODUCT SEGMENTS
TABLE 106. ADAMIS PHARMACEUTICALS CORPORATION: SERVICE SEGMENTS
TABLE 107. ADAMIS PHARMACEUTICALS CORPORATION: PRODUCT PORTFOLIO
TABLE 108. ADAMIS PHARMACEUTICALS CORPORATION: KEY STRATERGIES
TABLE 109. ADVACARE PHARMA: KEY EXECUTIVES
TABLE 110. ADVACARE PHARMA: COMPANY SNAPSHOT
TABLE 111. ADVACARE PHARMA: PRODUCT SEGMENTS
TABLE 112. ADVACARE PHARMA: SERVICE SEGMENTS
TABLE 113. ADVACARE PHARMA: PRODUCT PORTFOLIO
TABLE 114. ADVACARE PHARMA: KEY STRATERGIES
TABLE 115. ALK: KEY EXECUTIVES
TABLE 116. ALK: COMPANY SNAPSHOT
TABLE 117. ALK: PRODUCT SEGMENTS
TABLE 118. ALK: SERVICE SEGMENTS
TABLE 119. ALK: PRODUCT PORTFOLIO
TABLE 120. ALK: KEY STRATERGIES
TABLE 121. AMNEAL PHARMACEUTICALS LLC.: KEY EXECUTIVES
TABLE 122. AMNEAL PHARMACEUTICALS LLC.: COMPANY SNAPSHOT
TABLE 123. AMNEAL PHARMACEUTICALS LLC.: PRODUCT SEGMENTS
TABLE 124. AMNEAL PHARMACEUTICALS LLC.: SERVICE SEGMENTS
TABLE 125. AMNEAL PHARMACEUTICALS LLC.: PRODUCT PORTFOLIO
TABLE 126. AMNEAL PHARMACEUTICALS LLC.: KEY STRATERGIES
TABLE 127. AMPHASTAR PHARMACEUTICALS, INC.: KEY EXECUTIVES
TABLE 128. AMPHASTAR PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
TABLE 129. AMPHASTAR PHARMACEUTICALS, INC.: PRODUCT SEGMENTS
TABLE 130. AMPHASTAR PHARMACEUTICALS, INC.: SERVICE SEGMENTS
TABLE 131. AMPHASTAR PHARMACEUTICALS, INC.: PRODUCT PORTFOLIO
TABLE 132. AMPHASTAR PHARMACEUTICALS, INC.: KEY STRATERGIES
TABLE 133. GRAND PHARMA (CHINA) CO., LTD.: KEY EXECUTIVES
TABLE 134. GRAND PHARMA (CHINA) CO., LTD.: COMPANY SNAPSHOT
TABLE 135. GRAND PHARMA (CHINA) CO., LTD.: PRODUCT SEGMENTS
TABLE 136. GRAND PHARMA (CHINA) CO., LTD.: SERVICE SEGMENTS
TABLE 137. GRAND PHARMA (CHINA) CO., LTD.: PRODUCT PORTFOLIO
TABLE 138. GRAND PHARMA (CHINA) CO., LTD.: KEY STRATERGIES
TABLE 139. KALEO, INC.: KEY EXECUTIVES
TABLE 140. KALEO, INC.: COMPANY SNAPSHOT
TABLE 141. KALEO, INC.: PRODUCT SEGMENTS
TABLE 142. KALEO, INC.: SERVICE SEGMENTS
TABLE 143. KALEO, INC.: PRODUCT PORTFOLIO
TABLE 144. KALEO, INC.: KEY STRATERGIES
TABLE 145. PFIZER: KEY EXECUTIVES
TABLE 146. PFIZER: COMPANY SNAPSHOT
TABLE 147. PFIZER: PRODUCT SEGMENTS
TABLE 148. PFIZER: SERVICE SEGMENTS
TABLE 149. PFIZER: PRODUCT PORTFOLIO
TABLE 150. PFIZER: KEY STRATERGIES
TABLE 151. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 152. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 153. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SEGMENTS
TABLE 154. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SERVICE SEGMENTS
TABLE 155. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 156. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGIES
TABLE 157. VIATRIS INC.: KEY EXECUTIVES
TABLE 158. VIATRIS INC.: COMPANY SNAPSHOT
TABLE 159. VIATRIS INC.: PRODUCT SEGMENTS
TABLE 160. VIATRIS INC.: SERVICE SEGMENTS
TABLE 161. VIATRIS INC.: PRODUCT PORTFOLIO
TABLE 162. VIATRIS INC.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 01. EPINEPHRINE MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF EPINEPHRINE MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN EPINEPHRINE MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN EPINEPHRINE MARKET (2023-2032)
FIGURE 05. BARGAINING POWER OF SUPPLIERS
FIGURE 06. BARGAINING POWER OF BUYERS
FIGURE 07. THREAT OF SUBSTITUTION
FIGURE 08. THREAT OF SUBSTITUTION
FIGURE 09. COMPETITIVE RIVALRY
FIGURE 10. GLOBAL EPINEPHRINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. EPINEPHRINE MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR AUTO-INJECTOR, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR PREFILLED SYRINGE, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. EPINEPHRINE MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR ANAPHYLAXIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR CARDIAC ARREST, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL, 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF EPINEPHRINE MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. EPINEPHRINE MARKET BY REGION, 2022 AND 2032(%)
FIGURE 24. U.S. EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 25. CANADA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 26. MEXICO EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 27. GERMANY EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 28. FRANCE EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 29. UK EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 30. ITALY EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 31. SPAIN EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF EUROPE EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 33. JAPAN EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 34. CHINA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 35. INDIA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 36. AUSTRALIA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 37. SOUTH KOREA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 39. BRAZIL EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 40. COLOMBIA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 41. ARGENTINA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF LA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 43. GCC EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 44. SOUTH AFRICA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 45. NORTH AFRICA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 46. REST OF MEA EPINEPHRINE MARKET, 2022-2032 ($MILLION)
FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 51. COMPETITIVE DASHBOARD
FIGURE 52. COMPETITIVE HEATMAP: EPINEPHRINE MARKET
FIGURE 53. TOP PLAYER POSITIONING, 2022

Product Code: A65539

The epinephrine market was valued at $2.6 billion in 2022 and is projected to reach $4.4 billion by 2032, registering a CAGR of 5.6% from 2023 to 2032. Epinephrine, also known as adrenaline, is a hormone and neurotransmitter that plays a vital role in the body's response to stress or danger. It is produced by the adrenal glands, located on top of the kidneys. Epinephrine is released into the bloodstream in response to various stimuli, such as fear, stress, or excitement. Once released, epinephrine triggers a series of physiological responses aimed at preparing the body for action. These responses include increased heart rate, elevated blood pressure, dilation of the airways in the lungs to improve oxygen intake, and redirection of blood flow to the muscles. Epinephrine also enhances alertness and awareness, helping individuals react quickly to challenging situations.

It can be used medicinally, for instance, during ana-phylaxis (severe allergic reactions), cardiac arrest, bronchospasm, or other arrhythmias. Patients take epinephrine by injection inhalers or even nasal sprays; thus, the result helps them get ready for intense physical exertions and/or perceived threats by increase in circulation rates of blood through such mechanisms as air entry and energy availability, among others.

The epinephrine market is driven by the increase in incidence of allergic conditions such as anaphylaxis, asthma, and food allergies. These in turn can provoke strong and potentially lethal reactions that can require epinephrine use as a first line treatment. For instance, according to the American College of Allergy, Asthma, and Immunology (ACAAI), as of 2021, about 20 million people had food allergies in the U.S. Anaphylaxis is a severe and sometimes fatal allergic response that causes breathing problems, throat swelling or a sudden fall in blood pressure if people with devastating food allergies are accidentally exposed to them. In these cases, quick administration of epinephrine is essential to counteract dangerous symptoms, which drives the demand for epinephrine.

In addition, the growth of emergency medical services (EMS) has also been instrumental in propelling the demand for epinephrine within the industry. Paramedics and first responders who attend various life-threatening cases such as cardiac arrest and anaphylaxis among others, are usually given this medicine and thus, it forms a part of their emergency medical kits. The increased availability and accessibility of emergency medical services coupled with rise in demand for emergency care have been key contributors to growth in demand for epinephrine.

Furthermore, the aging population is another factor contributing to the growth of the epinephrine market. As people age, they become more susceptible to allergic reactions and chronic respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). In these cases, epinephrine may be prescribed as a life-saving medication to manage severe symptoms and prevent complications, which supports the market growth.

However, the regulatory challenges and stringent approval processes for epinephrine products can limit market growth. Regulatory agencies often impose rigorous standards for the manufacturing, labeling, and distribution of epinephrine medications to ensure their safety and efficacy lead to delays in product launches and increased costs for manufacturers, which negatively impacted the market growth. In contrast, technological advancements in drug delivery systems, such as the development of more user-friendly and convenient epinephrine auto-injectors, enhance patient compliance and market penetration. Such innovations in formulation techniques, packaging designs, and device usability are expected to create lucrative opportunities for market growth during the forecast period.

The epinephrine market is segmented on the basis of product type, application, distribution channel, and region. By product type, the market is classified into auto-injector, prefilled syringe, and others. By application, the market is divided into anaphylaxis, cardiac arrest, and others. By distribution channel, it is segregated into hospital pharmacy, drug stores and retail pharmacy, and online pharmacy. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).

Major key players that operate in the epinephrine market are Adamis Pharmaceuticals Corporation, AdvaCare Pharma, ALK-Abello A/S, Amneal Pharmaceuticals LLC., Amphastar Pharmaceuticals, Inc., Antares Pharma, kaleo, Inc., Pfizer, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Key players have adopted agreement and product approval as key developmental strategies to improve the product portfolio of the epinephrine market.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the epinephrine market analysis from 2022 to 2032 to identify the prevailing epinephrine market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the epinephrine market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global epinephrine market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

Auto-Injector
Prefilled Syringe
Others

By Application

Anaphylaxis
Cardiac Arrest
Others

By Distribution Channel

Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Providers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Colombia
- Argentina
- Rest Of La
Middle East and Africa
- Gcc
- South Africa
- North Africa
- Rest Of Mea

Key Market Players:

Adamis Pharmaceuticals Corporation
AdvaCare Pharma
ALK
Amneal Pharmaceuticals LLC.
Amphastar Pharmaceuticals, Inc.
Grand Pharma (China) Co., Ltd.
kaleo, Inc.
Pfizer
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: EPINEPHRINE MARKET, BY PRODUCT TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Auto-Injector
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Prefilled Syringe
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Others
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: EPINEPHRINE MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Anaphylaxis
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Cardiac Arrest
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospital Pharmacies
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Drug Stores and Retail Pharmacies
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Online Providers
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: EPINEPHRINE MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Product Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by Distribution Channel
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Product Type
  - 7.2.5.1.2. Market size and forecast, by Application
  - 7.2.5.1.3. Market size and forecast, by Distribution Channel
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Product Type
  - 7.2.5.2.2. Market size and forecast, by Application
  - 7.2.5.2.3. Market size and forecast, by Distribution Channel
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Product Type
  - 7.2.5.3.2. Market size and forecast, by Application
  - 7.2.5.3.3. Market size and forecast, by Distribution Channel
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Product Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by Distribution Channel
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Product Type
  - 7.3.5.1.2. Market size and forecast, by Application
  - 7.3.5.1.3. Market size and forecast, by Distribution Channel
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Product Type
  - 7.3.5.2.2. Market size and forecast, by Application
  - 7.3.5.2.3. Market size and forecast, by Distribution Channel
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Product Type
  - 7.3.5.3.2. Market size and forecast, by Application
  - 7.3.5.3.3. Market size and forecast, by Distribution Channel
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Product Type
  - 7.3.5.4.2. Market size and forecast, by Application
  - 7.3.5.4.3. Market size and forecast, by Distribution Channel
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Product Type
  - 7.3.5.5.2. Market size and forecast, by Application
  - 7.3.5.5.3. Market size and forecast, by Distribution Channel
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Product Type
  - 7.3.5.6.2. Market size and forecast, by Application
  - 7.3.5.6.3. Market size and forecast, by Distribution Channel
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Product Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by Distribution Channel
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Product Type
  - 7.4.5.1.2. Market size and forecast, by Application
  - 7.4.5.1.3. Market size and forecast, by Distribution Channel
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Product Type
  - 7.4.5.2.2. Market size and forecast, by Application
  - 7.4.5.2.3. Market size and forecast, by Distribution Channel
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Product Type
  - 7.4.5.3.2. Market size and forecast, by Application
  - 7.4.5.3.3. Market size and forecast, by Distribution Channel
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Market size and forecast, by Product Type
  - 7.4.5.4.2. Market size and forecast, by Application
  - 7.4.5.4.3. Market size and forecast, by Distribution Channel
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Market size and forecast, by Product Type
  - 7.4.5.5.2. Market size and forecast, by Application
  - 7.4.5.5.3. Market size and forecast, by Distribution Channel
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Product Type
  - 7.4.5.6.2. Market size and forecast, by Application
  - 7.4.5.6.3. Market size and forecast, by Distribution Channel
7.5. Latin America
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Product Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by Distribution Channel
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Product Type
  - 7.5.5.1.2. Market size and forecast, by Application
  - 7.5.5.1.3. Market size and forecast, by Distribution Channel
  - 7.5.5.2. Colombia
  - 7.5.5.2.1. Market size and forecast, by Product Type
  - 7.5.5.2.2. Market size and forecast, by Application
  - 7.5.5.2.3. Market size and forecast, by Distribution Channel
  - 7.5.5.3. Argentina
  - 7.5.5.3.1. Market size and forecast, by Product Type
  - 7.5.5.3.2. Market size and forecast, by Application
  - 7.5.5.3.3. Market size and forecast, by Distribution Channel
  - 7.5.5.4. Rest Of La
  - 7.5.5.4.1. Market size and forecast, by Product Type
  - 7.5.5.4.2. Market size and forecast, by Application
  - 7.5.5.4.3. Market size and forecast, by Distribution Channel
7.6. Middle East and Africa
- 7.6.1. Key market trends, growth factors and opportunities
- 7.6.2. Market size and forecast, by Product Type
- 7.6.3. Market size and forecast, by Application
- 7.6.4. Market size and forecast, by Distribution Channel
- 7.6.5. Market size and forecast, by country
  - 7.6.5.1. Gcc
  - 7.6.5.1.1. Market size and forecast, by Product Type
  - 7.6.5.1.2. Market size and forecast, by Application
  - 7.6.5.1.3. Market size and forecast, by Distribution Channel
  - 7.6.5.2. South Africa
  - 7.6.5.2.1. Market size and forecast, by Product Type
  - 7.6.5.2.2. Market size and forecast, by Application
  - 7.6.5.2.3. Market size and forecast, by Distribution Channel
  - 7.6.5.3. North Africa
  - 7.6.5.3.1. Market size and forecast, by Product Type
  - 7.6.5.3.2. Market size and forecast, by Application
  - 7.6.5.3.3. Market size and forecast, by Distribution Channel
  - 7.6.5.4. Rest Of Mea
  - 7.6.5.4.1. Market size and forecast, by Product Type
  - 7.6.5.4.2. Market size and forecast, by Application
  - 7.6.5.4.3. Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Adamis Pharmaceuticals Corporation
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
9.2. AdvaCare Pharma
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. ALK
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
9.4. Amneal Pharmaceuticals LLC.
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
9.5. Amphastar Pharmaceuticals, Inc.
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
9.6. Grand Pharma (China) Co., Ltd.
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
9.7. kaleo, Inc.
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
9.8. Pfizer
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
9.9. Teva Pharmaceutical Industries Ltd.
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
9.10. Viatris Inc.
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments

エピネフリンの世界市場：製品タイプ別、用途別、流通チャネル別：機会分析と産業予測（2023年～2032年）

Epinephrine Market By Product Type, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章エピネフリン市場：製品タイプ別

第5章エピネフリン市場：用途別

第6章エピネフリン市場：流通チャネル別

第7章エピネフリン市場：地域別

第8章競争情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

By Product Type

By Application

By Distribution Channel

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: EPINEPHRINE MARKET, BY PRODUCT TYPE

CHAPTER 5: EPINEPHRINE MARKET, BY APPLICATION

CHAPTER 6: EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 7: EPINEPHRINE MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

エピネフリンの世界市場：製品タイプ別、用途別、流通チャネル別：機会分析と産業予測（2023年～2032年）

Epinephrine Market By Product Type, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 エピネフリン市場：製品タイプ別

第5章 エピネフリン市場：用途別

第6章 エピネフリン市場：流通チャネル別

第7章 エピネフリン市場：地域別

第8章 競争情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

By Product Type

By Application

By Distribution Channel

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: EPINEPHRINE MARKET, BY PRODUCT TYPE

CHAPTER 5: EPINEPHRINE MARKET, BY APPLICATION

CHAPTER 6: EPINEPHRINE MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 7: EPINEPHRINE MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章エピネフリン市場：製品タイプ別

第5章エピネフリン市場：用途別

第6章エピネフリン市場：流通チャネル別

第7章エピネフリン市場：地域別

第8章競争情勢

第9章企業プロファイル